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Background: Although two main methods of intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC)
are currently accepted, the superiority of one over the other has not yet been demonstrated. The purpose of this
study was to determine whether there are hemodynamic and temperature differences between patients who
received HIPEC in two different techniques, open versus closed abdomen.
Methods: This retrospective study was conducted in our center between 2011–2015 in 30 patients who underwent
surgery for peritoneal carcinomatosis secondary to colorectal cancer, in whom cytoreduction and HIPEC were performed
by the Coliseum (15) or closed techniques (15). The main end points were morbidity, mortality, hemodynamic changes,
and abdominal temperature. The comparative analysis of quantitative variables at different times was done with the
parametric repeated measure ANOVA for those variables that fulfilled the suppositions of normality and independence
and the Friedman non-parametric test for the variables that did not fulfill either of these suppositions.
Results: There were no deaths in either group. The incidence of postoperative complications in the Coliseum group was
53% (8 patients), grade II–III. The incidence of complications in the closed group was 13% (2 patients), grade II–III. The
intra-operative conditions regarding the systolic and diastolic pressures were more stable using the closed abdomen
technique (but not significantly so). We found statistically significant differences in abdominal temperature in favor of the
closed technique (p = 0.009).
Conclusions: Both HIPEC procedures are similar. In our series, the closed technique resulted in a more stable intra-
abdominal temperature.
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In the past, peritoneal metastasis of colorectal carcinoma
was considered to be a terminal stage of the disease, as-
sociated with a poor prognosis, such that patients were
offered supportive care and systemic chemotherapy, with
or without palliative surgery [1]. Metastatic disease is
the main cause of death in patients with colorectal can-
cer but, unlike other tumors, its presence in either the
abdominal cavity or distant in the liver or lung does not
now prevent treatment with a curative intention in se-
lected groups of patients [2]. Since some 20 years ago,
an alternative treatment modality has been developed,
based on the combination of surgery associated with
chemotherapy, such that the macroscopic disease is
treated with cytoreductive surgery (CRS) followed by
treatment of the residual microscopic disease with intra-
operative hyperthermic intraperitoneal chemotherapy
(HIPEC) [1]. This integrated procedure has a curative
intention and aims to improve the quality of life and in-
crease the rates of survival. HIPEC can be undertaken in
several ways, with no clear advantage shown for any one
method over the others. The best known of these are the
Coliseum technique and the closed technique. Although
each HIPEC perfusion technique has its own advantages
and inconveniences, no controlled prospective studies
have compared the different methods of administration
[3]. As stated in Milan in 2006 at a consensus meeting
of the Peritoneal Surface Oncology Group International,
the debate is still open regarding the best method to per-
form the HIPEC procedure. Not enough scientific evi-
dence has yet been published to confirm the superiority
of one technique over the other [4].
The aim of this study was to assess the differences in
the intra-operative parameters during HIPEC adminis-
tration between the open and the closed techniques, as
well as to identify perioperative morbidity and mortality.
Methods
Patients
This retrospective cohort study comprised 30 patients
with peritoneal metastasis of colorectal origin, who all
fulfilled the criteria to undergo CRS and HIPEC at the
Regional University Hospital of Malaga, from December
2011 to March 2015. All the patients were assessed,
treated, and reviewed by the same surgical team. Most
of the patients were originally admitted to our own hos-
pital, with just 3 cases referred from other hospitals in
the Malaga area. The study was authorized by the hos-
pital Ethics Committee.
The inclusion criteria for patients to undergo the pro-
cedure included the following: an age between 18 and
70 years; patients with peritoneal metastasis with a peri-
toneal carcinomatosis index (PCI) ≤26; achievement of
macroscopically complete surgical cytoreduction or withtumor remains no greater than 2.5 mm, with a com-
pleteness of cytoreduction score (CC score) of 0 or 1;
patients with a life expectancy greater than 12 weeks
and with a performance status (Eastern Cooperative
Oncology Group) ≤2; patients with no extra-abdominal
tumors, <3 liver lesions that were technically resectable,
lack of biliary, and ureteral obstruction; patients in a
good general and nutritional state of health, with no se-
vere cardiac, lung, liver, kidney, or neurological condi-
tion that could contraindicate the surgery; and patients
with no signs of intestinal obstruction and who had an
adequate hematologic and hepatic balance. All patients
also had to provide specific written informed consent.
The following variables were recorded for each patient:
Preoperative variables: age, gender, ECOG perform-
ance status, anesthesia risk (according to the American
Society of Anesthesiologists (ASA)), body mass index,
and preoperative PCI. The preoperative PCI was
assessed from the findings of the preoperative abdomi-
nopelvic CT; in the event of doubt, the study was com-
pleted with PET-TC.
Intra-operative variables: PCI, degree of surgical ag-
gression established by the number of peritonectomies
and visceral resections required, HIPEC technique used,
CC score, and operative time.
Intra-HIPEC variables (measured at the end of the
cytoreduction, 15 min after starting HIPEC and at the
end of the procedure): hemodynamic parameters: O2 sat-
uration, systolic and diastolic blood pressure, central
venous pressure, heart rate, and maximum inspiratory
pressure. Intra-abdominal temperature: recorded at 10,
15, and 30 min after starting the procedure. The
hemodynamic parameters were measured via continuous
invasive monitoring. The intra-abdominal temperature
was recorded with thermal sensors incorporated into the
devices to administer the hyperthermia.
The outcome measures were perioperative morbidity
and mortality as well as contamination episodes.
HIPEC procedure
The HIPEC procedure was done following CRS. After
the incorporation in our service of HIPEC, we initially
started with the Coliseum technique for 2 years, after
which we adopted the closed technique, which we con-
tinue to use, mainly because of technical improvements
and a lower incidence of operating room contamination
by chemotherapeutic agents. For us, the technique is
more comfortable and safer, avoiding overflow and con-
tamination of operating room personnel, in addition to
which its efficacy has been well documented. The cyto-
static agent used in both techniques was oxaliplatin at a
dose of 460 mg/m2 of body surface area, diluted for per-
fusion in 2 L/m2 of glucose solution at 5%, maintaining
the perfusion circuit at a constant flow of 0.5–0.7 L/min
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therapy to potentiate the intra-peritoneal oxaliplatin
by the intravenous administration of folinic acid
20 mg/m2, followed by 400 mg/m2 of 5-FU in perfu-
sion for 30 min, infused 1 h before the HIPEC. In
both techniques, we used three intra-abdominal ther-
mometers (placed in the areas of the pelvis and
diaphragm) to monitor the temperature in the peri-
toneal cavity during perfusion. We also routinely used
a probe with an esophageal temperature sensor to
monitor the core temperature of the patient. In the
HIPEC Coliseum cases, we used a standard technique
(described by Sugarbaker). Abdominal wall suspension
is achieved with a suture, creating a Coliseum for the
instillation of the peritoneal perfusate placing two in-
flow and two outflow catheters, with a blood recovery
device adapted for HIPEC as an infusion pump
(Belmont®). The infusion pump forces the perfusate of
chemotherapeutic drugs into the abdomen through a
Tenckoff catheter and extracts it through the drains,
with an approximate flow rate of 1 L/min. A heat ex-
changer keeps the infused fluid at 43–45 °C so that
the intra-peritoneal fluid is maintained at about 41–
43 °C. The perfusate first recirculates between the
reservoir and the heat exchanger in order for it to
reach the suitable temperature. At this point, full cir-
culation of the perfusate into and out of the periton-
eal cavity is established until achieving a minimum
intra-peritoneal temperature of 41.5 °C. The chemo-
therapeutic drug is then included in the circuit, at
which stage the perfusion timer is started. The perfu-
sion in the cases that underwent closed HIPEC was
done in a closed circuit, with placement of two inflow
catheters in close proximity to the retroperitoneum
and one more superficial outflow catheter. This tech-
nique differs from the open technique in that the skin
is completely sutured along the laparotomy so that
the perfusion is given in a closed circuit. The position
of the patient is varied during the perfusion by inclin-
ing the operating table in the Trendelenburg and
antiTrendelenburg positions and laterally in order to
achieve homogeneous distribution of the heat. In
comparison with the open technique, a greater vol-
ume of fluid is needed in the closed technique to
establish the circuit; in addition to which greater
intra-abdominal pressures are obtained during the
perfusion. In these cases, we used the chemotherapy
infusion pump from Evomed®. After the hyperthermic
perfusion, the abdomen is again opened and the anas-
tomoses, stomas, and placement of drains are done.
Finally, the abdomen is closed definitively in the
standard manner.
All the patients in both groups received the same
anesthesia protocol.Statistical analysis
Initially, a descriptive analysis was made of the study
variables, using central tendency and dispersion statistics
for the continuous variables. The qualitative variables
were studied with frequency distribution tables and their
percentages. The comparative analysis of quantitative
variables at different times was done with the parametric
repeated measure ANOVA for those variables that ful-
filled the suppositions of normality and independence,
and the Friedman non-parametric test for the variables
that did not fulfill either of these suppositions. This ana-
lysis was necessary as our objective was to compare
observations taken on the same subject over time. To
test the suppositions of normality and independence, we
used the Shapiro-Wilk test and the Rachas test, respect-
ively. A p < 0.05 was considered as significant in all
cases. The statistical analysis was done with SPSS v. 17.0
(Chicago, Illinois, USA).
Results
Our series comprised a total of 30 patients who under-
went CRS followed by HIPEC.
General data
All the patients in both groups shared similar demo-
graphic, clinical, and therapeutic features (Table 1). The
median age of the patients was 52 years (range 33–
66 years), with 16 women and 14 men. All the patients
had an ECOG of 0. Analysis of the anesthetic risk (ASA)
showed that 20 patients were ASA II, followed by 9 with
an ASA of III. Only 1 patient was ASA I. In the series,
17 patients had synchronous peritoneal metastasis, with
13 having metachronous metastasis. In these latter, the
median time to appearance of the metastasis was
10 months after surgery for the primary tumor (most in
stages pT3N2aM0) and the corresponding adjuvant ther-
apy. The median BMI of the series was 25.12 kg/m2
(range 19.7–43.9 kg/m2), and the median preoperative
PCI was 5.52 (range 0–20). In the Coliseum group, 9 pa-
tients received chemotherapy prior to the procedure,
while 4 patients in the closed technique group received
neoadjuvant therapy.
A total of 30 CRS plus HIPEC procedures were per-
formed. We performed peritonectomy procedures in-
cluding a large xyphopubic laparotomy, assessing the
extension of the peritoneal disease. Staging of the degree
of tumor involvement was done with the PCI. All the
patients underwent the same surgical procedure, starting
with the pelviperitonectomy, resecting the uterus and
the adnexa if these were affected, as well as the Douglas
pouch. If the rectosigmoid was affected, it was also
resected en bloc, with reconstruction of the tract by
colorectal anastomosis (or ileorectal in the patients who
required total colectomy) with a 29 mm circular stapler.
Table 1 Patient characteristics in both groups of treatment, n= 30







Origin of peritoneal metastasis Colorectal cancer Colorectal cancer
Timing of peritoneal metástasis
Synchronous 6 7
Metachronous 8 9
Performance status (ECOG) 0 0
Anesthetic risk (ASA) ASA I→1
ASA II→10 ASA II→10
ASA III→4 ASA III→5
Median of body mass index (BMI) 25,09 25,15
Median preoperative PCI (peritoneal
carcinomatosis index)
5,40 5,57
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ing on the patient risk factors and the nature of the
anastomosis. In the event of implants infiltrating the
small intestine and depending on their size, intestinal
resections with anastomosis were done or fulguration
with the round end of the electro-cauterizer. Cytore-
duction of the rest of the peritoneal cavity was then
done, systematically performing a complete omentect-
omy. We always used at least one drain for abdom-
inal aspiration placed in the pelvis, and in those
patients who underwent intestinal anastomosis, we
placed another aspiration drain nearby.
The median number of peritonectomy and visceral
resection procedures required in the HIPEC Coliseum
group was 3 (range 0–4), with omentectomy being
the most usual, followed by pelviperitonectomy and
excision of small bowel implants. The median num-
ber of peritonectomy and visceral resection proce-
dures required in the closed HIPEC group was 3
(range 0–4), with pelviperitonectomy and omentect-
omy being the most usual, followed by excision of
small bowel implants and splenectomy. The median
intra-operative PCI was 7.58 (range 0–20). After the
CRS, 15 patients underwent closed HIPEC and 15
patients received HIPEC with the Coliseum tech-
nique. The CC score attained after the CRS proce-
dures was 0 in all cases in both treatment groups.
The median number of anastomoses performed in
both groups was 2 (range 0–3). The median opera-
tive time in both groups was 480 min (range 270–
660 min for HIPEC Coliseum and 240–660 min for
closed HIPEC). Only one episode of accidental intra-
operative contamination from chemotherapeutic
agents was recorded in the HIPEC Coliseum group,
with no episodes in the closed HIPEC group (differ-
ence not statistically significant; p = 0.37).Intra-HIPEC variables
No statistically significant differences were observed for
any of the hemodynamic parameters studied (Fig. 1).
The diastolic blood pressure figures varied less during
the procedure in the closed technique, being more stable
than those with the Coliseum technique. Though the
difference was not significant (p = 0.09), there was a cer-
tain tendency. The central venous pressure figures varied
more during the closed technique compared with the
Coliseum technique; again not significantly (p = 0.08)
but with a tendency. Finally, the intra-abdominal
temperature remained more stable and homogenous
during the closed technique throughout the procedure,
varying less than with the Coliseum technique; this dif-
ference was statistically significant (p = 0.009).
Morbidity and mortality
All complications arising during the first 30 postopera-
tive days were recorded, classified according to Dindo-
Clavien. The incidence of postoperative complications in
the HIPEC Coliseum group was 53% (8 patients), all oc-
curring during the early postoperative period (first
15 days). The complications were grade II: urinary fistula
requiring percutaneous nephrostomy, nosocomial pneu-
monia (2 cases), rhabdomyolysis, and acute pulmonary
edema; grade IIIA (2 cases): intra-abdominal abscess
treated with percutaneous drainage and hepatic abscess
that required percutaneous drainage; and grade IIIB (1
case): abdominal sepsis secondary to bacterial transloca-
tion that necessitated urgent re-operation. The incidence
of complications in the closed HIPEC group was 13% (2
patients). These were grade II (surgical wound infection)
and grade IIIB (acute pulmonary edema and acute re-
spiratory failure that required mechanical ventilation).
The differences found concerning morbidity were
mainly influenced by the fact that most of the patients
in the Coliseum group had received chemotherapy be-
fore the procedure (9 cases), whereas only 4 cases who
underwent the closed technique had received chemo-
therapy. Even so, the difference was not statistically
significant (p = 0.23). Moreover, the complications oc-
curring in the Coliseum group mainly required just
conservative management, with just one patient need-
ing urgent re-operation. In the closed technique
group, the complications also mainly required just
conservative management, with no patient needing ur-
gent re-operation. No death occurred in either of the
treatment groups.
Discussion
The Milan Consensus of 2006 concluded that the most
used HIPEC technique was currently the Coliseum tech-
nique. This argument was based on the fact that no
major advantages have been shown with the open
Fig. 1 Hemodynamic parameters and abdominal temperature registered during the HIPEC procedure in both groups. a O2 saturation. The blue
line corresponds to Coliseum technique. The red line corresponds to closed technique. b Systolic blood pressure. The blue line corresponds to
Coliseum technique. The red line corresponds to closed technique. c Diastolic blood pressure. The blue line corresponds to Coliseum technique.
The red line corresponds to closed technique. d Central venous pressure. The blue line corresponds to Coliseum technique. The red line corresponds to
closed technique. e Heart rate. The blue line corresponds to Coliseum technique. The red line corresponds to closed technique. f Maximum inspiratory
pressure. The blue line corresponds to Coliseum technique. The red line corresponds to closed technique. g Abdominal temperature. The blue line
corresponds to the Coliseum modality. The red line corresponds to closed technique
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bidity or mortality or surgical safety [5].
The present study showed that there are no statisti-
cally significant differences in the postoperative morbid-
ity and mortality with the implementation of either
technique. While the analysis of the hemodynamic pa-
rameters evaluated did not yield any statistically signifi-
cant differences either, it appears that the closed
technique is associated with more stable intra-operative
conditions (principally related to the systolic and dia-
stolic blood pressure), exposing the patient to a lesser
stress. This proves to be especially helpful in frail pa-
tients, with suboptimal preoperative status (older age,
comorbidities, and cachexia).
Regarding the hemodynamic monitoring, the present
study showed that parameters such as the central venous
pressure, heart rate, systolic and diastolic blood pressure,
and O2 saturation do not differ significantly with the
two techniques (p = 0.08, p = 0.47, p = 0.13, p = 0.09, and
p = 0.17, respectively). These findings are in accordance
with those of Halkia et al., who reported a retrospective
study of 105 patients who underwent CRS and HIPEC,
comparing the two techniques. They found no signifi-
cant differences concerning the hemodynamic parame-
ters between the techniques. A more stable perioperative
situation was noted (though not significantly so) with
the closed technique versus the Coliseum technique but
with very narrow ranges [6]. However, this is not the
case with the intra-abdominal temperature. A similar
situation was found by Pascual-Ramírez et al. [7], who
detected no differences in hemodynamic parameters
during CRS and HIPEC when describing the closed
technique in ovarian cancer patients. This had also been
reported in the study by Desgranges et al. [8].
In our series, we observed differences in heart rate be-
tween the open and the closed techniques (increased in
the closed technique group). Pascual-Ramírez also re-
ported an increase in heart rate, attributed to increased
vasodilatation and relative volume deficit due to heat in-
crease. Indeed, we observed more stable perioperative
conditions with the closed technique when we analyzed
the systolic and diastolic blood pressure readings,
though the differences were not statistically significant
to those of the open technique, but with narrower
ranges, as found by Halkia et al. For the other study pa-
rameters, although greater alterations were detected in
the closed HIPEC group, the differences were not statis-
tically significant. However, this observation cannot be
evaluated with statistical methods, perhaps owing to the
small statistical sample being a limitation of our study.
Schmidt et al., in a retrospective analysis of 78 patients
undergoing CRS and HIPEC demonstrated a large intra-
operative fluid turnover, an increased airway pressure
and central venous pressure (due to the increasedintra-abdominal pressure with the closed technique),
while the increased body temperature resulted in a mild
metabolic acidosis; findings in line with those seen in
our study in the closed HIPEC group but with no statis-
tical significance [6, 9].
Facy et al. studied a swine model submitted to
closed HIPEC and found that the increase in intra-
abdominal pressure produced with the closed tech-
nique caused tachycardia, a more aggressive reduction
in blood pressure requiring more energetic fluid re-
suscitation and an increase in ventilation pressure,
with stable oxygen saturation, as occurred in our
study in the group that underwent surgery with the
closed HIPEC technique [6, 10, 11].
Likewise, Cafiero et al., in a study of 15 patients who
underwent closed HIPEC, noted that when the intra-
abdominal pressure rose there was a reduction in venous
return, associated with a drop in abdominal blood vol-
ume and a rise in peripheral vascular resistance. On the
other hand, they also saw a significant rise in the heart
rate, central venous pressure, and pulmonary artery
pressure during perfusion (as we also found). These au-
thors concluded that the closed HIPEC procedure is safe
for both the patient and the surgical personnel such that
the artificial ascites produced does not cause dangerous
hemodynamic changes [12].
Schluermann et al. studied 10 patients who underwent
closed HIPEC and found similar results concerning the
heart rate and central venous pressure. The authors
noted that during the closed HIPEC procedure, there
was an increase in intra-abdominal pressure associated
with a significant reduction in peripheral vascular resist-
ance and an increase in heart rate. These findings could
be explained by the appearance of a systemic inflamma-
tory reaction and various mechanisms of physiological
adaptation to the increase in body temperature [13].
In our study, we saw that the temperature in the
closed HIPEC group was more stable throughout the
whole procedure as compared with the Coliseum group.
We noted that the intra-abdominal temperature reached
the maximum value 15 min after starting the procedure,
in both HIPEC techniques. However, there was a pro-
gressive fall with effect from 15 min, more pronounced
with the Coliseum technique. This latter is because it is
more complex to maintain a constant intra-abdominal
temperature balance as the procedure is open, in
addition to which it requires stirring by the surgeon’s
hand, which increases intra-abdominal heat dissipation.
Additionally, it is influenced by the low operating room
temperature and the measures adopted by the
anesthetist to avoid hyperthermia, such as removal of
the thermal blanket and fluid and electrolyte replace-
ment with cold fluids during the procedure. Nonethe-
less, to confront this, we increased the temperature of
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visceral thermal lesions. In the case of the closed HIPEC
technique, while the factor of heat dispersion is not
present, the situation is still influenced by other circum-
stances, such as the low operating room temperature
and the measures to avoid hyperthermia.
At the end of the HIPEC procedure, that is at 30 min,
temperatures of nearly 39 °C were recorded. This is in
line with what has been mentioned earlier; during the
procedure the patient experiences a progressive loss of
intra-abdominal temperature, despite the hyperthermal
administration of fluids, due to heat loss generated by
the temperature conditions in the operating room and
the measures adopted by the anesthetist to prevent
hyperthermia. This loss is more marked with the
Coliseum technique than the closed technique. Despite
this however, when we noted suboptimal temperatures
during the procedure, we attempted to compensate by
raising the temperature of the inflowing fluid. The differ-
ences found in intra-abdominal temperature were statis-
tically significant (p = 0.0009).
Some studies have shown that the closed technique
does not guarantee thermal homogeneity. Ortega-
Deballon et al. undertook a study in an animal model to
compare the open and closed techniques in nine pigs
with the aim of analyzing the thermal homogeneity and
diffusion of the chemotherapeutic agent. Hyperthermia
was achieved in both study arms, but it was not homo-
geneous in the closed technique group. This is due to
the proximity of the inflow catheters to the diaphragm
in the absence of stirring in the closed technique. Never-
theless, the problem concerning stirring the fluid inside
the abdominal cavity when using the closed technique,
and thus maintaining thermal homogeneity with this
technique, could be solved by undertaking a closed
HIPEC using a laparoscopic approach, thus enabling
uniform distribution of temperature and cytotoxic
agents. This constitutes a future line of research to im-
prove heat distribution during HIPEC [14]. The high dis-
sipation of heat in the open technique could explain the
need for greater flow when a heat pump is used [4, 6].
Padmanabhan et al. found difficulties maintaining the
intra-abdominal temperature with the Coliseum technique,
which is why they then used the closed technique in the
other cases. They based this on the fact that one of the
great advantages of the closed technique is the minimal ex-
posure of operating room personnel to the chemotherapeu-
tic agent as well as the better maintenance of the intra-
abdominal temperature [4, 15–19]. Our findings agree with
those seen by Padmanabhan et al. However, the beneficial
effect of the high intra-abdominal pressure that can theor-
etically be achieved with the closed technique may be offset
by the existence of preferential circuits with under-treated
areas of the abdominal cavity during HIPEC [4, 20].Conclusions
Both the open and the closed abdomen techniques are
safe and efficient methods of HIPEC delivery in the
treatment of peritoneal carcinomatosis.
In our series use of the closed technique was associated
with fewer hemodynamic alterations relating to the sys-
tolic and diastolic blood pressure readings in comparison
with the Coliseum technique, though the differences were
not statistically significant. Nevertheless, the closed
technique resulted in less variation in intra-abdominal
temperature, which was significantly more stable through-
out the procedure.
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